These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 12545156)
1. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Wu S; Cetinkaya C; Munoz-Alonso MJ; von der Lehr N; Bahram F; Beuger V; Eilers M; Leon J; Larsson LG Oncogene; 2003 Jan; 22(3):351-60. PubMed ID: 12545156 [TBL] [Abstract][Full Text] [Related]
2. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Seoane J; Le HV; Massagué J Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701 [TBL] [Abstract][Full Text] [Related]
3. Repression of p15INK4b expression by Myc through association with Miz-1. Staller P; Peukert K; Kiermaier A; Seoane J; Lukas J; Karsunky H; Möröy T; Bartek J; Massagué J; Hänel F; Eilers M Nat Cell Biol; 2001 Apr; 3(4):392-9. PubMed ID: 11283613 [TBL] [Abstract][Full Text] [Related]
4. Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc. Kime L; Wright SC Biochem J; 2003 Feb; 370(Pt 1):291-8. PubMed ID: 12418961 [TBL] [Abstract][Full Text] [Related]
5. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Seoane J; Pouponnot C; Staller P; Schader M; Eilers M; Massagué J Nat Cell Biol; 2001 Apr; 3(4):400-8. PubMed ID: 11283614 [TBL] [Abstract][Full Text] [Related]
6. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts. Marcotte R; Chen JM; Huard S; Wang E J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342 [TBL] [Abstract][Full Text] [Related]
7. AP4 encodes a c-MYC-inducible repressor of p21. Jung P; Menssen A; Mayr D; Hermeking H Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15046-51. PubMed ID: 18818310 [TBL] [Abstract][Full Text] [Related]
8. An alternative pathway for gene regulation by Myc. Peukert K; Staller P; Schneider A; Carmichael G; Hänel F; Eilers M EMBO J; 1997 Sep; 16(18):5672-86. PubMed ID: 9312026 [TBL] [Abstract][Full Text] [Related]
9. Negative regulation of the mammalian UV response by Myc through association with Miz-1. Herold S; Wanzel M; Beuger V; Frohme C; Beul D; Hillukkala T; Syvaoja J; Saluz HP; Haenel F; Eilers M Mol Cell; 2002 Sep; 10(3):509-21. PubMed ID: 12408820 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells. Mitchell KO; El-Deiry WS Cell Growth Differ; 1999 Apr; 10(4):223-30. PubMed ID: 10319992 [TBL] [Abstract][Full Text] [Related]
11. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells. Ma H; Urquidi V; Wong J; Kleeman J; Goodison S Mol Cancer Res; 2003 Aug; 1(10):739-46. PubMed ID: 12939399 [TBL] [Abstract][Full Text] [Related]
12. De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene. Ikegaki N; Gotoh T; Kung B; Riceberg JS; Kim DY; Zhao H; Rappaport EF; Hicks SL; Seeger RC; Tang XX Clin Cancer Res; 2007 Oct; 13(20):6001-9. PubMed ID: 17947461 [TBL] [Abstract][Full Text] [Related]
13. Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region. Zhang J; Chen S; Zhang W; Zhang J; Liu X; Shi H; Che H; Wang W; Li F; Yao L Gene; 2008 Jul; 417(1-2):5-12. PubMed ID: 18455888 [TBL] [Abstract][Full Text] [Related]
14. DNA topoisomerase II inhibitor, etoposide, induces p21WAF1/CIP1 through down-regulation of c-Myc in K562 cells. Horiguchi-Yamada J; Fukumi S; Saito S; Nakayama R; Iwase S; Yamada H Anticancer Res; 2002; 22(6C):3827-32. PubMed ID: 12553001 [TBL] [Abstract][Full Text] [Related]
15. USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry. Moriuchi M; Moriuchi H; Margolis DM; Fauci AS J Immunol; 1999 May; 162(10):5986-92. PubMed ID: 10229837 [TBL] [Abstract][Full Text] [Related]
16. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Phan RT; Saito M; Basso K; Niu H; Dalla-Favera R Nat Immunol; 2005 Oct; 6(10):1054-60. PubMed ID: 16142238 [TBL] [Abstract][Full Text] [Related]
17. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product. Luo Q; Li J; Cenkci B; Kretzner L Oncogene; 2004 Feb; 23(5):1088-97. PubMed ID: 14716294 [TBL] [Abstract][Full Text] [Related]
18. Cell-cycle progression is not essential for c-Myc to block differentiation. Ryan KM; Birnie GD Oncogene; 1997 Jun; 14(23):2835-43. PubMed ID: 9190900 [TBL] [Abstract][Full Text] [Related]
19. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc. Wang LG; Liu XM; Fang Y; Dai W; Chiao FB; Puccio GM; Feng J; Liu D; Chiao JW Int J Oncol; 2008 Aug; 33(2):375-80. PubMed ID: 18636159 [TBL] [Abstract][Full Text] [Related]
20. Regulation of c-Myc and Max in megakaryocytic and monocytic-macrophagic differentiation of K562 cells induced by protein kinase C modifiers: c-Myc is down-regulated but does not inhibit differentiation. Lerga A; Crespo P; Berciano M; Delgado MD; Cañelles M; Calés C; Richard C; Ceballos E; Gutierrez P; Ajenjo N; Gutkind S; León J Cell Growth Differ; 1999 Sep; 10(9):639-54. PubMed ID: 10511314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]